Neuroimaging and blood markers as indicators of ketamine efficacy in treatment resistant depression

  • Coffey, Eleanor (Ansvarig forskare)
  • Walter, Martin (CoPI)
  • Sartorius, Alexander (Ansvarig forskare)
  • Lecourtier, Lucas (Ansvarig forskare)

Projektinformation

Beskrivning

This is a ERANET funded clinical study to identify predictive markers for ketamine treatment.
Kort titel334776 Coffey ERANET
StatusSlutfört
Gällande start-/slutdatum01/04/2031/03/24

Finansiering

  • Finlands Akademi